A recent Medgadget article discussed a new type of vaccine that doesn’t require cold chain for transport. The vaccine, which was developed by researchers at the University of Queensland and Vaxxas, comes via a high-density microarray patch for a minimally invasive delivery without the use of needles. However, the most impressive part is the formulation’s stability; it can be stored for a month at room temperature, and a week at 104 degrees Fahrenheit. A video with more information can be seen here.
This COVID-19 Vaccine Doesn’t Require Cold Chain
The microarray patch vaccine can be stored for a month at room temperature and remain effective.
Nov 11, 2021
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!